Dr. Caralynn V. Nowinski

• 
  www.midamericahealthcareforum.com/2008/advisory.html - [Cached Version]
  Published on: 6/13/2009    Last Visited: 6/13/2009  

  Caralynn Nowinski, M.D.
  ...
  Caralynn Nowinski, M.D.
  ...
  Caralynn Nowinski Associate Midwest Venture Partners Dr. Nowinski is an Associate with Midwest Venture Partners and ARCH Development Partners, where she takes an active role in due diligence, financial modeling/valuation and monitoring of current portfolio companies. As a joint MD/MBA student at the University of Illinois at Chicago, she co-founded SanoGene Therapeutics, an early-stage biotech company, and she currently serves as its President and Acting CEO. Prior to medical school, Dr. Nowinski managed two NIH-funded clinical research programs, authoring several peer-reviewed scientific articles in the neurosciences. She graduated with honors (B.S.) from Northwestern University.

• 
  www.midamericahealthcareforum.com/advisory.html - [Cached Version]
  Published on: 8/3/2008    Last Visited: 8/3/2008  

  Caralynn Nowinski, M.D.
  ...
  Caralynn Nowinski, M.D.
  ...
  Caralynn NowinskiAssociateMidwest Venture Partners Members ListDr. Nowinski is an Associate with Midwest Venture Partners and ARCH Development Partners, where she takes an active role in due diligence, financial modeling/valuation and monitoring of current portfolio companies.As a joint MD/MBA student at the University of Illinois at Chicago, she co-founded SanoGene Therapeutics, an early-stage biotech company, and she currently serves as its President and Acting CEO.Prior to medical school, Dr. Nowinski managed two NIH-funded clinical research programs, authoring several peer-reviewed scientific articles in the neurosciences.She graduated with honors (B.S.) from Northwestern University.

• 
  c-e-o.preationdev.com/page.php?mode=privateview&pageID= - [Cached Version]
  Last Visited: 8/29/2009  

  Caralynn Nowinski - SanoGene Therapeutics Inc.

• 
  www.c-e-o.org/pages/173/2008-National-Conference/ - [Cached Version]
  Last Visited: 1/5/2009  

  Caralynn Nowinski - SanoGene Therapeutics Inc.

• 
  www.wisconsinangelnetwork.com/uploads/Newsletter/eVesto - [Cached Version]
  Published on: 1/1/2009    Last Visited: 10/18/2009  

  Caralynn Nowinski, associate, Midwest Venture Partners, Chicago

• 
  Concept2Venture.org - business plan competition at UIC - [Cached Version]
  Published on: 3/16/2007    Last Visited: 9/25/2008  

  Caralynn V. NowinskiCo-founder of Sano Gene Therapeutics
  ...
  C2V® 2005 Winner Sano Gene, a team of two MBA students, Caralynn Nowinski and Chirag Patel, won several national and international competitions and accumulated more than $150,000 of awards, enough to start up their company.
  ...
  Ms. Nowinski told us about her experience at C2V and how it worked as a kick-off for other competitions.
  
  To see her comment about UIC MBA and its entrepreneur program, please click here.
  
  To see her comment about ENTR555 new venture formation class, please click here.

• 
  Contact at SanoGene Therapeutics Inc. - [Cached Version]
  Published on: 10/18/2009    Last Visited: 10/18/2009  

  Caralynn V. Nowinski, Acting CEO

• 
  I2V Urbana 2009 Speakers - [Cached Version]
  Last Visited: 8/13/2009  

  Caralynn Nowinski-Chenoweth
  ...
  Caralynn Nowinski-Chenoweth, Associate of Midwest Venture Partners and ARCH Development Partners
  ...
  Caralynn Nowinski-Chenoweth, M.D., is an Associate with Midwest Venture Partners and ARCH Development Partners, where she plays an active role in the investment process, working with early-stage, technology-focused portfolio companies. While pursuing a joint MD/MBA at the University of Illinois at Chicago, she co-founded SanoGene Therapeutics, an early-stage biotechnology spin-out, and currently serves as the company's President and Acting CEO. Under her leadership, SanoGene received a strategic equity investment, was recognized as the winner of seven business plan competitions, and has been featured in Business Week Chicago, the Chicago Tribune and the New York Times. Her research in cognitive neuroscience has led to several published journal articles and book chapters. Caralynn was recently named to Crain's Chicago Business 2008 "Forty Under Forty" List.

• 
  Illinois Technology Development Alliance - [Cached Version]
  Published on: 12/1/2008    Last Visited: 9/25/2009  

  Caralynn Nowinski - Midwest Venture Partners

• 
  Management at SanoGene Therapeutics Inc. - [Cached Version]
  Published on: 10/18/2009    Last Visited: 10/18/2009  

  Caralynn V. Nowinski, M.D./MBA - Co-Founder, President & Interim CEO With experience in clinical trials, research operations management and seed-stage venture capital, Dr. Nowinski brings talent and dedication to SanoGene's management team and has positioned the Company to effectively carry out its initial operations. Under her leadership, SanoGene spun out from the University of Illinois College of Medicine, raised a strategic equity investment, was recognized as the winner of eight business plan competitions and has been featured in Business Week Chicago, the Chicago Tribune and the New York Times. As an Associate with venture capital firms Midwest Venture Partners and ARCH Development Partners, Dr. Nowinski plays an active role in sourcing, due diligence and monitoring of early-stage, technology-focused portfolio companies. Prior to medical school, she managed two NIH-funded clinical research programs, authoring several published journal articles and book chapters in cognitive neuroscience. Among her honors, Dr. Nowinski was recently named to Crain's Chicago Business 2008 "Forty Under Forty" List. She received M.D. and MBA degrees from the University of Illinois at Chicago and graduated with honors (B.S.) from Northwestern University. Dr. Nowinski is an Active Member of the Society for Neuro-Oncology.
  ...
  Dr. Eisner applies his 14 years of research experience to supervising SanoGene's nonclinical operations and works closely with Dr. Nowinski to manage business development relationships and execute SanoGene's operational plan.

Page:  1 2